O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+16.19%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.79B
AUM Growth
+$8.79B
(+13%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
37.24%
Holding
144
New
16
Increased
26
Reduced
29
Closed
10
Top Buys
| 1 |
Centene
CNC
|
$118M |
| 2 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$74.8M |
| 3 |
Merck
MRK
|
$69.9M |
| 4 |
AET
Aetna Inc
AET
|
$64.6M |
| 5 |
Viatris
VTRS
|
$50.7M |
Top Sells
| 1 |
Amgen
AMGN
|
$147M |
| 2 |
Neurocrine Biosciences
NBIX
|
$73.1M |
| 3 |
Intuitive Surgical
ISRG
|
$72.9M |
| 4 |
AGN
Allergan plc
AGN
|
$69.8M |
| 5 |
AbbVie
ABBV
|
$55.1M |
Sector Composition
| 1 | Healthcare | 93.33% |
| 2 | Financials | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
1
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $450M | 5.1% | 3,710,986 +322,600 | +10% | +$39.1M |
|
2
Biogen
BIIB
$19.4B
| $393M | 4.45% | 1,436,900 +155,700 | +12% | +$42.6M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $390M | 4.42% | 3,132,177 +25,400 | +0.8% | +$3.16M |
|
4
Boston Scientific
BSX
$156B
| $381M | 4.32% | 15,311,400 -1,195,500 | -7% | -$29.7M |
|
|
5
Merck
MRK
$210B
| $363M | 4.12% | 5,714,900 +1,099,700 | +24% | +$69.9M |
|
6
Eli Lilly
LLY
$657B
| $280M | 3.18% | 3,330,200 +591,200 | +22% | +$49.7M |
|
|
WMGI
7
DELISTED
Wright Medical Group Inc
WMGI
| $278M | 3.16% | 8,946,234 +1,361,900 | +18% | +$42.4M |
|
8
Incyte
INCY
$16.5B
| $264M | 2.99% | 1,973,597 -109,203 | -5% | -$14.6M |
|
9
Vertex Pharmaceuticals
VRTX
$100B
| $237M | 2.69% | 2,169,200 +9,800 | +0.5% | +$1.07M |
|
|
10
Amgen
AMGN
$155B
| $236M | 2.67% | 1,438,300 -893,500 | -38% | -$147M |
|
11
Agilent Technologies
A
$35.7B
| $192M | 2.18% | 3,629,900 | – | – |
|
12
Pfizer
PFE
$141B
| $185M | 2.1% | 5,406,100 +238,200 | +5% | +$8.15M |
|
13
Edwards Lifesciences
EW
$47.8B
| $173M | 1.96% | 1,839,300 +487,900 | +36% | +$45.9M |
|
|
AET
14
DELISTED
Aetna Inc
AET
| $167M | 1.9% | 1,312,400 +506,500 | +63% | +$64.6M |
|
|
SHPG
15
DELISTED
Shire pic
SHPG
| $156M | 1.77% | 897,451 -305,900 | -25% | -$53.3M |
|
16
HCA Healthcare
HCA
$94.5B
| $155M | 1.76% | 1,745,000 -257,200 | -13% | -$22.9M |
|
17
Humana
HUM
$36.5B
| $153M | 1.73% | 742,300 -94,100 | -11% | -$19.4M |
|
18
Regeneron Pharmaceuticals
REGN
$61.5B
| $147M | 1.66% | 378,170 +22,870 | +6% | +$8.86M |
|
19
Elevance Health
ELV
$71.8B
| $143M | 1.62% | 862,600 -159,000 | -16% | -$26.3M |
|
|
20
AbbVie
ABBV
$372B
| $136M | 1.54% | 2,080,000 -845,000 | -29% | -$55.1M |
|
|
ARRY
21
DELISTED
Array Biopharma Inc
ARRY
| $127M | 1.44% | 14,182,900 -1,905,900 | -12% | -$17M |
|
22
Ironwood Pharmaceuticals
IRWD
$214M
| $124M | 1.4% | 7,241,300 | – | – |
|
|
23
Centene
CNC
$14.3B
| $118M | 1.34% | +1,655,700 | New | +$118M |
|
|
ICPT
24
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $117M | 1.33% | 1,037,000 -83,000 | -7% | -$9.39M |
|
|
AGN
25
DELISTED
Allergan plc
AGN
| $114M | 1.29% | 477,390 -292,300 | -38% | -$69.8M |
|